Qualigen Therapeutics Inc
NASDAQ:QLGN
Income Statement
Earnings Waterfall
Qualigen Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-11.3m
USD
|
Operating Income
|
-11.3m
USD
|
Other Expenses
|
-2.1m
USD
|
Net Income
|
-13.4m
USD
|
Income Statement
Qualigen Therapeutics Inc
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
2
+93%
|
3
+64%
|
5
+67%
|
5
+5%
|
5
+6%
|
6
+7%
|
4
-21%
|
5
+7%
|
5
+6%
|
5
-2%
|
6
+18%
|
6
+3%
|
5
-24%
|
0
N/A
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-80%
|
0
+950%
|
1
+338%
|
1
+11%
|
1
+24%
|
1
+5%
|
1
-61%
|
1
+25%
|
1
N/A
|
1
+6%
|
1
+65%
|
1
+25%
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(1)
|
(2)
|
(3)
|
(5)
|
(8)
|
(9)
|
(11)
|
(13)
|
(13)
|
(18)
|
(17)
|
(15)
|
(13)
|
(8)
|
(8)
|
(10)
|
(13)
|
(17)
|
(20)
|
(19)
|
(17)
|
(11)
|
(6)
|
(7)
|
(11)
|
(18)
|
(23)
|
(24)
|
(24)
|
(22)
|
(19)
|
(19)
|
(19)
|
(18)
|
(17)
|
(19)
|
(11)
|
|
Selling, General & Administrative |
(1)
|
(2)
|
(3)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(6)
|
(7)
|
(10)
|
(11)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(11)
|
(11)
|
(9)
|
(6)
|
|
Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(4)
|
(7)
|
(8)
|
(13)
|
(12)
|
(10)
|
(8)
|
(3)
|
(3)
|
(4)
|
(7)
|
(11)
|
(14)
|
(14)
|
(11)
|
(6)
|
(2)
|
(2)
|
(3)
|
(7)
|
(11)
|
(12)
|
(12)
|
(10)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(5)
|
|
Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
|
Operating Income |
(1)
N/A
|
(2)
-75%
|
(3)
-49%
|
(5)
-50%
|
(8)
-56%
|
(9)
-12%
|
(11)
-20%
|
(13)
-19%
|
(13)
-3%
|
(18)
-40%
|
(17)
+8%
|
(15)
+13%
|
(13)
+10%
|
(8)
+40%
|
(8)
-5%
|
(10)
-20%
|
(13)
-27%
|
(17)
-35%
|
(20)
-16%
|
(19)
+4%
|
(17)
+13%
|
(11)
+34%
|
(6)
+47%
|
(7)
-27%
|
(11)
-44%
|
(17)
-64%
|
(22)
-28%
|
(23)
-5%
|
(23)
+2%
|
(22)
+4%
|
(19)
+15%
|
(18)
+2%
|
(18)
+1%
|
(17)
+7%
|
(16)
+4%
|
(14)
+10%
|
(11)
+22%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(5)
|
(5)
|
(5)
|
(2)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
(15)
|
(20)
|
(8)
|
(8)
|
10
|
17
|
5
|
5
|
3
|
1
|
1
|
1
|
2
|
1
|
2
|
|
Pre-Tax Income |
(1)
N/A
|
(2)
-90%
|
(4)
-45%
|
(5)
-48%
|
(8)
-53%
|
(9)
-9%
|
(11)
-20%
|
(13)
-19%
|
(13)
-4%
|
(18)
-41%
|
(17)
+8%
|
(15)
+13%
|
(13)
+10%
|
(8)
+41%
|
(8)
-4%
|
(10)
-20%
|
(12)
-27%
|
(17)
-35%
|
(20)
-16%
|
(19)
+4%
|
(16)
+13%
|
(10)
+38%
|
(21)
-109%
|
(27)
-28%
|
(20)
+28%
|
(25)
-27%
|
(12)
+53%
|
(7)
+44%
|
(18)
-174%
|
(17)
+5%
|
(16)
+8%
|
(17)
-6%
|
(21)
-27%
|
(21)
+0%
|
(21)
+3%
|
(20)
+4%
|
(12)
+37%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(1)
|
(2)
|
(4)
|
(5)
|
(8)
|
(9)
|
(11)
|
(13)
|
(13)
|
(18)
|
(17)
|
(15)
|
(13)
|
(8)
|
(8)
|
(10)
|
(12)
|
(17)
|
(20)
|
(19)
|
(16)
|
(10)
|
(21)
|
(27)
|
(20)
|
(25)
|
(12)
|
(7)
|
(18)
|
(17)
|
(16)
|
(17)
|
(21)
|
(21)
|
(20)
|
(19)
|
(12)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
2
|
0
|
|
Net Income (Common) |
(2)
N/A
|
(3)
-76%
|
(4)
-37%
|
(6)
-42%
|
(9)
-45%
|
(9)
-6%
|
(11)
-17%
|
(13)
-17%
|
(13)
-4%
|
(18)
-41%
|
(17)
+8%
|
(15)
+13%
|
(13)
+10%
|
(11)
+17%
|
(11)
-3%
|
(13)
-14%
|
(16)
-20%
|
(19)
-25%
|
(22)
-14%
|
(21)
+3%
|
(19)
+12%
|
(10)
+46%
|
(21)
-109%
|
(27)
-28%
|
(20)
+28%
|
(25)
-27%
|
(12)
+53%
|
(7)
+44%
|
(18)
-174%
|
(17)
+5%
|
(16)
+8%
|
(16)
-5%
|
(19)
-13%
|
(18)
+3%
|
(18)
+4%
|
(17)
+1%
|
(13)
+23%
|
|
EPS (Diluted) |
-779.26
N/A
|
-1 369.24
-76%
|
-1 874.91
-37%
|
-2 663.53
-42%
|
-3 467.44
-30%
|
-7 786.96
-125%
|
-4 842.1
+38%
|
-5 018.94
-4%
|
-5 057.44
-1%
|
-5 110.64
-1%
|
-4 449.08
+13%
|
-1 474.99
+67%
|
-1 323
+10%
|
-1 097
+17%
|
-565.49
+48%
|
-646.5
-14%
|
-778.5
-20%
|
-970.5
-25%
|
-736.66
+24%
|
-533.49
+28%
|
-471.5
+12%
|
-253.25
+46%
|
-24.35
+90%
|
-13.7
+44%
|
-11.23
+18%
|
-8.78
+22%
|
-4.01
+54%
|
-2.25
+44%
|
-6.1
-171%
|
-4.81
+21%
|
-4.27
+11%
|
-4.18
+2%
|
-4.85
-16%
|
-3.66
+25%
|
-3.46
+5%
|
-3.43
+1%
|
-2.64
+23%
|